Loading...
Please wait, while we are loading the content...
Similar Documents
MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Gal, Hilah Pandi, Gopal Kanner, A. A. Lithwick-Yanai, Gila Amariglio, Ninette Rechavi, Gideon Givol, David |
| Copyright Year | 2008 |
| Abstract | We examined the microRNA profiles of Glioblastoma stem (CD133+) and non-stem (CD133-) cell populations and found up-regulation of several miRs in the CD133- cells, including miR-451, miR-486, and miR-425, some of which may be involved in regulation of brain differentiation. Transfection of GBM cells with the above miRs inhibited neurosphere formation and transfection with the mature miR-451 dispersed neurospheres, and inhibited GBM cell growth. Furthermore, transfection of miR-451 combined with Imatinib mesylate treatment had a cooperative effect in dispersal of GBM neurospheres. In addition, we identified a target site for SMAD in the promoter region of miR-451 and showed that SMAD3 and 4 activate such a promoter-luciferase construct. Transfection of SMAD in GBM cells inhibited their growth, suggesting that SMAD may drive GBM stem cells to differentiate to CD133- cells through up-regulation of miR-451 and reduces their tumorigenicity. Identification of additional miRs and target genes that regulate GBM stem cells may provide new potential drugs for therapy. |
| Starting Page | 86 |
| Ending Page | 90 |
| Page Count | 5 |
| File Format | PDF HTM / HTML |
| DOI | 10.1016/j.bbrc.2008.08.107 |
| PubMed reference number | 18765229 |
| Journal | Medline |
| Volume Number | 376 |
| Issue Number | 1 |
| Alternate Webpage(s) | http://www.brainlife.org/abstract/2008/gal_h080831.pdf |
| Journal | Biochemical and biophysical research communications |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |